Simone Nicolardi

Simone Nicolardi

Auto-generated profile, based on publicly available information

Simone Nicolardi

Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MDM. Dilillo
M. Dilillo
RAR. Ait-Belkacem
R. Ait-Belkacem
CEC. Esteve
C. Esteve
DPD. Pellegrini
D. Pellegrini
SNS. Nicolardi
S. Nicolardi
LMLiam Andrew McDonnell
Liam Andrew McDonnell
MALDI mass spectrometry imaging is able to simultaneously determine the spatial distribution of hundreds of molecules directly from tissue sections, without labeling and without prior knowledge. Ultra-high mass resolution measurements based on Fourier-transform mass spectrometry have been utilized to resolve isobaric lipids, metabolites and tryptic peptides. Here we demonstrate the potential of 15T MALDI-FTICR MSI for molecular pathology in a mouse model of high-grade glioma. The high mass accuracy and resolving power of high field FTICR MSI enabled tumor specific proteoforms, and tumor-specific proteins with overlapping and isobaric isotopic distributions to be clearly resolved. The protein ions detected by MALDI MSI were assigned to proteins identified by region-specific microproteomics (0.8 mm2 regions isolated using laser capture microdissection) on the basis of exact mass and isotopic distribution. These label free quantitative experiments also confirmed the protein expression changes observed by MALDI MSI and revealed changes in key metabolic proteins, which were supported by in-situ metabolite MALDI MSI.

19 August 2020 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Closed access
KSKristina Srzentić
Kristina Srzentić
LFLuca Fornelli
Luca Fornelli
YTYury O. Tsybin
Yury O. Tsybin
JLJoseph A. Loo
Joseph A. Loo
HSHenrique Seckler
Henrique Seckler
MZMowei Zhou
Mowei Zhou

27 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
Pilar Garcia-VelloPilar Garcia-Vello
Pilar Garcia-Vello
HTHanne L. P. Tytgat
Hanne L. P. Tytgat
JEJanneke Elzinga
Janneke Elzinga
MHMatthias Van Hul
Matthias Van Hul
HPHubert Plovier
Hubert Plovier
WVWillem M De Vos
Willem M De Vos
The cell-envelope of Gram-negative bacteria contains endotoxic lipopolysaccharides (LPS) that are recognized by the innate immune system via Toll-Like Receptors (TLRs). The intestinal mucosal symbiont Akkermansia muciniphila is known to confer beneficial effects on the host and has a Gram-negative architecture. Here we show that A. muciniphila LPS lacks the O-polysaccharide repeating unit, with the resulting lipooligosaccharide (LOS) having unprecedented structural and signaling properties. The LOS consists of a complex glycan chain bearing two distinct undeca- and hexadecasaccharide units each containing three 2-keto-3-deoxy-D-manno-octulosonic acid (Kdo) residues. The lipid A moiety appears as a mixture of differently phosphorylated and acylated species and carries either linear or branched acyl moieties. Peritoneal injection of the LOS in mice increased higher gene expression of liver TLR2 than TLR4 (100-fold) and induced high IL-10 gene expression. A. muciniphila LOS was found to signal both through TLR4 and TLR2, whereas lipid A only induced TLR2 in a human cell line. We propose that the unique structure of the A. muciniphila LOS allows interaction with TLR2, thus generating an anti-inflammatory response as to compensate for the canonical inflammatory signaling associated with LOS and TLR4, rationalizing its beneficial host interaction.

19 September 2018 in Analytical Chemistry
Verified
Journal Article
Open access
GVGerda C. M. Vreeker
Gerda C. M. Vreeker
SNSimone Nicolardi
Simone Nicolardi
MBMarco Bladergroen
Marco Bladergroen
CPCorné J. van der Plas
Corné J. van der Plas
WMWilma E. Mesker
Wilma E. Mesker
MWManfred Wuhrer
Manfred Wuhrer
High throughput mass spectrometry (MS) glycomics is an emerging field driven by technological advancements including sample preparation and data processing. Previously, we reported an automated protocol for the analysis of N-glycans released from plasma proteins that included sialic acid derivatization with linkage-specificity, namely ethylation of α2,6-linked sialic acid residues and lactone formation of α2,3-linked sialic acids. In the current study, each step in this protocol was further optimized. Method improvements included minimizing the extent of side-reaction during derivatization, an adjusted glycan purification strategy and mass analysis of the released N-glycans by ultrahigh resolution matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance MS. The latter resolved peak overlap and simplified spectral alignment due to high mass measurement precision. Moreover, this resulted in more confident glycan assignments and improved signal-to-noise for low-abundant species. The performance of the protocol renders high-throughput applications feasible in the exciting field of clinical glycomics.

20 December 2018 in Analytical Chemistry
Verified
Journal Article
Open access
YBYuri E.M. Van Der Burgt
Yuri E.M. Van Der Burgt
DKDavid Peter Alexander Kilgour
David Peter Alexander Kilgour
YTYury O. Tsybin
Yury O. Tsybin
KSKristina Srzentić
Kristina Srzentić
LFLuca Fornelli
Luca Fornelli
SNSimone Nicolardi
Simone Nicolardi
The emergence of complex protein therapeutics in general and monoclonal antibodies (mAbs) in particular have stimulated analytical chemists to develop new methods and strategies for their structural characterization. Mass spectrometry (MS) plays a key role in providing information on the primary amino acid sequence, post-translational modifications and other structure characteristics that must be monitored during the manufacturing process and subsequent quality control assessment. In this study, we present a novel method that allows structural characterization of mAbs based on MALDI in-source decay (ISD) fragmentation, coupled with Fourier transform ion cyclotron resonance (FT-ICR) MS. The method benefits from higher resolution of absorption mode FT mass spectra, compared to magnitude mode, which enabled simultaneous identification of ISD fragments from both the heavy and light chains with a higher confidence in a wide mass range up to m/z 13,500. This method was applied to two standard mAbs, namely NIST mAb and trastuzumab, in preparation for method application in an inter-laboratory study on mAbs structural analysis coordinated by the Consortium for Top-Down Proteomics. Extensive sequence coverage was obtained from the middle-down analysis (IdeS- and GingisKHAN-digested mAbs) that complemented the top-down analysis of intact mAbs. In addition, MALDI FT-ICR MS of IdeS-digested mAbs allowed isotopic-level profiling of proteoforms with regard to heavy chain N-glycosylation.

26 February 2015 in Analytical Chemistry
Verified
Journal Article
Open access
SNSimone Nicolardi
Simone Nicolardi
LSLinda Switzar
Linda Switzar
ADAndré M. Deelder
André M. Deelder
MPMagnus Palmblad
Magnus Palmblad
YBYuri E.M. Van Der Burgt
Yuri E.M. Van Der Burgt
An accurate mass measurement of a known protein provides information on potential amino acid deletions and post-translational modifications. Although this field is dominated by strategies based on electrospray ionization, mass spectrometry (MS) methods using matrix-assisted laser desorption/ionization (MALDI) have the advantage of yielding predominantly singly charged precursor ions, thus avoiding peak overlap from different charge states of multiple species. Such MALDI-MS methods require mass measurement at ultrahigh resolution, which is provided by Fourier transform ion cyclotron resonance (FTICR) mass analyzers. Recently, using a MALDI-FTICR-MS platform equipped with a 15 T magnet, we reported on the mass analysis of intact human serum peptides and small proteins with isotopic resolution up to ∼15 kDa and identified new proteoforms from an accurate measurement of mass distances. In the current study, we have used this FTICR system after an upgrade with a novel dynamically harmonized ICR cell, i.e., ParaCell, for mapping isotopically resolved intact proteins up to about 17 kDa and performed top-down MALDI in-source decay (ISD) analysis. Standard proteins myoglobin (m/z-value 16 950) and ribonuclease B (m/z-value 14 900) were measured with resolving powers of 62 000 and 61 000, respectively. Furthermore, it will be shown that (singly charged) MALDI-ISD fragment ions can be measured at isotopic resolution up to m/z-value 12 000 (e.g., resolving power 39 000 at m/z-value 12 000) providing more reliable identifications. Moreover, examples are presented of pseudo-MS3 experiments on ISD fragment ions from RNase B by collisional-induced dissociation (CID).